SWAV

Russell 2000 below the 200-day average

Overview →

SWAV News

About

shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen

Industry
Surgical and Medical Instrument Manufacturing
CEO
Douglas Godshall
Leadership (11)
Isaac ZachariasPresident & Chief Commercial Officer
Daniel HawkinsFounder and Senior Advisor
Dave CoxVice President of Sales
Douglas E. GodshallPresident, Chief Executive Officer & Director
Hajime TadaGeneral Counsel & Secretary
John AdamsCo-Founder and Technical Advisor
Luis MoralesSenior Vice President of Global Operations
Robert FletcherSenior Vice President of Marketing & Market Access
Debbie KasterVice President of Investor Relations
Trinh PhungChief Accounting Officer, Principal Accounting Officer & Vice President of Finance
Renee GaetaChief Financial Officer
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.